Melius Research downgraded Ingersoll-Rand (IR) to Hold from Buy with a $93 price target While Melius continues to see Ingersoll-Rand as a core holding, the firm doesn’t have a compelling case for outperformance, the analyst tells investors in a research note. This quarter could see some margin relief from tariffs, but the resolution of tariff uncertainty continues to be delayed, while the Big Beautiful Bill has put a lot of uncertainty into clean tech and healthcare end markets, the firm says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IR:
- Ingersoll-Rand downgraded to Hold from Buy at Melius Research
- Ingersoll-Rand price target raised to $92 from $85 at Barclays
- Ingersoll-Rand acquires Termomeccanica Industrial Compressors, terms undisclosed
- Ingersoll-Rand price target raised to $95 from $86 at Wells Fargo
- Ingersoll Rand Positioned for Long-Term Growth: Buy Rating Affirmed by Andrew Kaplowitz